The China Mail - Who should get paid for nature's sequenced genes?

USD -
AED 3.67302
AFN 71.536303
ALL 90.405912
AMD 389.77481
ANG 1.790208
AOA 916.000215
ARS 1075.195997
AUD 1.650451
AWG 1.8025
AZN 1.701353
BAM 1.787694
BBD 2.01692
BDT 121.35421
BGN 1.78943
BHD 0.376878
BIF 2969.307768
BMD 1
BND 1.349349
BOB 6.902572
BRL 5.864301
BSD 0.998862
BTN 86.097134
BWP 14.0993
BYN 3.269024
BYR 19600
BZD 2.006481
CAD 1.41663
CDF 2871.000113
CHF 0.853705
CLF 0.025679
CLP 985.179964
CNY 7.308597
CNH 7.35606
COP 4392.25
CRC 512.832233
CUC 1
CUP 26.5
CVE 100.785609
CZK 22.955301
DJF 177.879144
DKK 6.81729
DOP 62.655095
DZD 133.824968
EGP 51.246803
ERN 15
ETB 131.715138
EUR 0.913235
FJD 2.329971
FKP 0.785678
GBP 0.78207
GEL 2.750262
GGP 0.785678
GHS 15.497748
GIP 0.785678
GMD 72.17057
GNF 8663.804194
GTQ 7.715806
GYD 209.409415
HKD 7.76796
HNL 25.628127
HRK 6.888099
HTG 131.583485
HUF 373.917226
IDR 16852.692308
ILS 3.75926
IMP 0.785678
INR 85.932969
IQD 1312.060987
IRR 42111.979176
ISK 132.744003
JEP 0.785678
JMD 157.736833
JOD 0.709007
JPY 146.708965
KES 129.511174
KGS 86.805951
KHR 4005.661669
KMF 450.692198
KPW 899.976479
KRW 1470.494017
KWD 0.307863
KYD 0.829268
KZT 521.040525
LAK 21690.770454
LBP 89906.628583
LKR 296.695051
LRD 200.280625
LSL 19.577283
LTL 2.95274
LVL 0.60489
LYD 4.934084
MAD 9.561565
MDL 17.754528
MGA 4633.203922
MKD 56.254848
MMK 2099.38476
MNT 3509.76811
MOP 8.002611
MRU 39.949261
MUR 45.080826
MVR 15.445222
MWK 1736.03677
MXN 20.52737
MYR 4.478796
MZN 63.817034
NAD 19.577283
NGN 1576.150318
NIO 36.838353
NOK 10.91382
NPR 137.557201
NZD 1.783883
OMR 0.384984
PAB 1
PEN 3.681492
PGK 4.055324
PHP 57.330483
PKR 280.729906
PLN 3.930989
PYG 8022.7182
QAR 3.640269
RON 4.560348
RSD 107.305119
RUB 86.162468
RWF 1430.455354
SAR 3.750049
SBD 8.500642
SCR 14.575794
SDG 600.12631
SEK 10.025175
SGD 1.35208
SHP 0.785843
SLE 22.749797
SLL 20969.501083
SOS 574.116425
SRD 36.572442
STD 20697.981008
SVC 8.749944
SYP 13001.558046
SZL 19.577283
THB 34.746653
TJS 10.871664
TMT 3.498288
TND 3.080342
TOP 2.406281
TRY 38.009625
TTD 6.783843
TWD 33.03309
TZS 2681.884327
UAH 41.206967
UGX 3696.64109
UYU 42.556096
UZS 12996.655465
VES 72.084089
VND 25793.538418
VUV 125.059451
WST 2.843211
XAF 600.922931
XAG 0.032875
XAU 0.000331
XCD 2.706586
XDR 0.749413
XOF 600.922931
XPF 109.319941
YER 245.795492
ZAR 19.343225
ZMK 9001.205638
ZMW 27.939123
ZWL 321.999592
  • CMSC

    -0.1200

    22.17

    -0.54%

  • RYCEF

    -0.0800

    8.15

    -0.98%

  • RBGPF

    60.2700

    60.27

    +100%

  • SCS

    -0.3800

    10.2

    -3.73%

  • AZN

    -2.6700

    65.79

    -4.06%

  • RIO

    -0.1100

    54.56

    -0.2%

  • GSK

    -1.6900

    34.84

    -4.85%

  • RELX

    -2.6300

    45.53

    -5.78%

  • BCE

    -0.6300

    22.08

    -2.85%

  • BTI

    -0.4300

    39.43

    -1.09%

  • VOD

    -0.1500

    8.35

    -1.8%

  • JRI

    -0.7000

    11.26

    -6.22%

  • NGG

    -3.0300

    62.9

    -4.82%

  • CMSD

    -0.3500

    22.48

    -1.56%

  • BCC

    -3.5500

    91.89

    -3.86%

  • BP

    -1.2100

    27.17

    -4.45%

Who should get paid for nature's sequenced genes?
Who should get paid for nature's sequenced genes? / Photo: © AFP/File

Who should get paid for nature's sequenced genes?

Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.

Text size:

The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.

Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.

"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.

"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.

Much of the information comes from poor countries.

Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.

At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).

Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?

- 'Cheap and very fast' -

The issue is a complex one.

There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.

But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?

"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.

These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.

DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.

"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.

"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.

- Mandatory -

A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.

They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.

"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.

Another sticking point is access for Indigenous people and local communities to DSI funds.

Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.

But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.

With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.

The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.

Added Barber: "I think it's not going to all get solved here."

Y.Su--ThChM